Company
Synthetic Biology
Our Platform
Operating Units & Divisions
Subsidiaries
Management
Board of Directors
Our Commitment
Technologies
UltraVector
®
RheoSwitch
®
Cell Systems Informatics
Protein Engineering
AttSite™ Recombinases
LEAP
®
Antibody Discovery
Neurospora & Agaricus Platforms
Endometrial Regenerative Cells
ActoBiotics
®
Porcine Research Models
BeyondBio™
Scientific Literature
Markets
Health
Food
Energy
Environment
Consumer
Collaborations
Exclusive Channel Collaborations
Joint Ventures
Private Companies
Office of Academic Alliances & Technology Licensing
Partnering Opportunities
Investors
Overview
Press Releases
Collaborator News
Stock Information
Corporate Governance
SEC Filings
Events/Conferences
Investors Packet
FAQ
Information Request
IRS Form 8937
Careers
Contact
Contact
Search
At Intrexon we are committed to building…
A Better World Through Better DNA™
Whether engineering novel therapies in health, delivering unique solutions to address global energy demand, enabling unparalleled productivity advancements in food, or developing innovative applications in the consumer and environment sectors, we are working diligently today to create a better tomorrow.
Engineering novel solutions in
HEALTH
to achieve improved outcomes
Building a sustainable path to produce healthy, affordable
FOOD
Utilizing a proprietary bioconversion platform for efficient
ENERGY
products
Developing innovative solutions for the
ENVIRONMENT
Designing bio based
CONSUMER
solutions
At Intrexon we are committed to building…
A Better World Through Better DNA™
IN THE NEWS
2/13/2017
Lt. Gen. (Ret.) Thomas P. Bostick, Head of Intrexon’s Environment Sector, Elected to National Academy of Engineering
1/31/2017
ZIOPHARM Utilizing Non-Viral Sleeping Beauty Platform to Rapidly Produce CAR-Expressing T cells Advancing "Point-of-Care" Approach
1/26/2017
Exemplar Genetics Awarded Subcontract to Advance New Therapeutic Models for Sickle Cell Disease
1/24/2017
Intrexon to Acquire GenVec to Expand Industry-Leading Gene Delivery Platform
1/23/2017
Oxitec and GBIT announce launch of Friendly™ Aedes Project in India
1/19/2017
AquaBounty Announces Completion of NASDAQ Listing and Equity Subscription from Intrexon
1/12/2017
Intrexon Announces “When-Issued” Trading of AquaBounty Technologies In Connection With Special Stock Dividend of Shares
ENGINEERING SOLUTIONS
Oxitec's Vector Control Solution: A Paradigm Shift
in Mosquito Control
Forging a New Frontier in Cellular Therapeutics:
Oral ActoBiotics
®
Biopharmaceuticals
Precise Gene Expression:
Proprietary RheoSwitch
®
Technology Platform